Jean Mercier Ythier is professor of economics at the University Paris-Panthéon-Assas, France. He graduated from the Institute of Political Studies of Paris (PhD, 1989). He was also a graduate student at Harvard University (1986-87). He went notably through positions of invited research fellow at the University of Montréal (Québec, Canada), assistant professor and associate professor of economics at the University of Paris Panthéon-Sorbonne and professor of economics at the University of Lorraine (France). Prof. Jean Mercier Paris-Panthéon-Assas Ythier's research interests include the theory of general competitive equilibrium, microeconomic theory, public economic theory, economic philosophy, altruism, ethics, and topics of economic anthropology.

Dr. Giurgiu Gheorghe is the CEO of Deniplant in Rome, Italy. Previous he worked as Producer of the Melotherapy radio show. in 2007 Deniplant got Trademark registration at Ohim Spain. Deniplant is an European Brand. Gheorghe Giurgiu was sick with psoriasis for 7 years (1976-1983) and with Deniplant natural remedies he was cured. After this experience carefully researching the beneficial health effects of food, spices and other natural ingredients, Deniplant Natural Remedies natural modulators of the human microbiome for the treatment and healing of autoimmune, metabolic and neurological disorders.

Pamela Gebhardt, Master of Science in nursing administration and education has over 40 years of experience across diverse clinical settings, including ICU/CCU, Med/Surg, PACU, and Oncology. She held progressive leadership roles, overseeing policy development, quality assurance, and regulatory compliance. Pamela earned a Master of Science in Administration and Education from the University of Arizona and a Bachelor of Science in Nursing from Westminster College. Graduating with honors. She has published articles in nursing magazines, edited chapters in nursing books, and received several achievement awards throughout her career. Pamela deeply believes in the nobility of the nursing profession and the profound impact nurses have on the lives of patients and their families. She has been married for 49 years and has grown children. Pamela currently cares for her husband who has Parkinson's Disease. She is grateful for a fulfilling career dedicated to improving the health and well-being of others.

Peter A. Averkiou, M.D., F.A.A.P., is a board certified pediatrician, who was in private practice for 20 years in Boca Raton, Florida. In 2012, he joined the faculty of the Charles E. Schmidt College of Medicine at Florida Atlantic University as an Assistant Professor of Integrated Medical Science. Dr. Averkiou is the Co-Director of M1 and M2 Clinical Education. He is also the Director of the Newborn Nursery Clinical Rotation and the Director of the Service Learning Projects. Dr. Averkiou serves as a Learning Community/Portfolio Advisor. He is also on the Interprofessional Education Development Sessions Committee and the YMCA Diabetes Prevention Program Advisory Board. Dr. Averkiou is a Diplomate of the American Board of Pediatrics and a Fellow of the American Academy of Pediatrics. His goal is to train the medical students to be excellent clinicians and compassionate doctors.

As a seasoned medical professional, I bring a wealth of experience in both clinical practice and medical education leadership. I am equipped with strong personal attributes including a robust work ethic, unwavering dedication, integrity, adaptability, and the ability to efficiently prioritize tasks with little oversight while still achieving excellent outcomes. I am adept at learning quickly and possess outstanding problem-solving capabilities, a deep-seated passion for healthcare, and a dedication to providing patient care grounded in evidence-based practices. Beyond my clinical and educational roles, I have extensive knowledge in management and leadership, with a focus on implementing transformative practices, fostering team cohesion, and enhancing both critical thinking and problem-solving abilities. I excel at building high-performing teams driven by authentic and effective leadership. My advanced understanding of business administration, health policy, and financial management has significantly contributed to my career progression. Additionally, my skills in forging partnerships, fostering collaborative relationships, working cooperatively, and initiating projects have been instrumental and enriching components of my professional journey in recent years.

Dr. David Wortley is Vice President of the International Society of Digital Medicine (ISDM). Virtual Conferences Director at IORMA Global Commerce Consultancy. CEO and Founder of 360in360 Immersive Experiences. Expert Consultant on Gamification and Enabling Technologies. Authority on the practical application of immersive technologies and gamification in health, business and education.

Professor Dr. Mohammad Kamil, M.Sc.; M.Phil.; Ph.D.; D.Sc.; Chartered Chemist(U.K.) and Fellow Royal Society of Chemistry (London), worked in various capacities, as In-charge –of the Drug Standardization lab. Professor & Head Department of Pharmacognostic Science, Zayed Complex for Herbal Research & Traditional. Medicine(ZCHRTM), Ministry of Health, UAE (1996-2010); Head TCAM Research at ZCHRTM, Department of Health(DOH)Abu Dhabi (2010-2020), presently working as Director General, Lotus Holistic Healthcare Institute, Abu Dhabi, UAE since 2021 and Head, Scientific Committee for Sheikh Zayed International TCAM Awards and General Secretary for First Sheikh Zayed TCAM International Award October 2024. He is a recipient of Man of the year 2002, ABI, USA; Hakim Ajmal Khan Global Award in Unani Medicine, India(2014); Honorary Trustee, International Unani Forum (Oct’2022 -March 2025). More than 700 research papers in reputed journals & and presentations at international conferences are at his credit. He has been associated with the World Health Organization (WHO) in the revision of the Benchmark for International Standards of Unani Medicine Terminology and Training of Unani Medicine, as its drafting expert and their subsequent reviews.

Priya Hays, M.S., Ph.D. is an accomplished science writer, having written and published five books as well as having authored over twenty publications in journals as varied as the Bulletin of Science, Technology and Society, L’Esprit Createur, Interdisciplinary Literary Studies, Genetics in Medicine, Journal of Clinical Investigation and Studies, and Preventive Medicine, Epidemiology and Public Health, Journal of Clinical Oncology and Journal of Immunotherapy for Cancer. The second edition for her book on personalized medicine, Advancing Healthcare Through Personalized Medicine, was released in 2021. She is served as Guest Editor for a volume on cancer immunotherapies in the Cancer Treatment and Research series. Her most recent book is a compilation of papers entitled “A Dialectical Mind: Essays in Literary Studies, Science and Medicine” published by Eliva Press. She completed her postdoctoral research fellowship in the Division of Hematology/Oncology, Department of Medicine, at Dartmouth Medical School. She has an A.B. with Honors from Dartmouth College in Biochemistry and Comparative Literature, an M.S. in Genetics from the University of California, Davis, and a Ph.D. in Literature from the University of California, San Diego.

Dr. Nizar Assaad is an Experienced Director Of Nursing with a demonstrated history of working in the hospital & health care industry. Skilled in Healthcare Information Technology (HIT), Electronic Medical Record (EMR), Nursing, Clinical Research, and Critical Care. Strong healthcare services professional with a Master degree in healthcare management focused in Health/Health Care Administration/Management from University of Atlanta.

Dr. Shankar is an Assistant Professor (Research) in the Division of Medical Oncology, Department of Internal Medicine, at The Ohio State University, Columbus, Ohio, USA. Trained as a neuroscientist, Dr. Shankar holds a Ph.D. in Molecular Neurobiology from Cochin University of Science and Technology, Kerala India. Driven by a deep commitment to advancing cancer research, Dr. Shankar has dedicated their career to deciphering the molecular complexities of breast and prostate cancers. His research is anchored in uncovering novel chemotherapeutic and chemopreventive approaches, particularly by leveraging the potential of drug repurposing. At the heart of Dr. Shankar's research is an innovative focus on Enhancer of Zeste Homolog 2 (EZH2), a critical epigenetic regulator involved in cancer progression. Recognizing its role in the aggressive and metastatic behaviors of breast and prostate cancers, Dr. Shankar and their team are pioneering the development of combinatorial treatments targeting EZH2. This groundbreaking research, supported by funding from the Department of Defense, USA, aims to provide new therapeutic strategies to combat Triple Negative Breast Cancer in the United States. By integrating drug repurposing strategies with advanced molecular insights, Dr. Shankar's work contributes to a promising frontier in oncology, with the potential to yield highly targeted, effective treatments for patients facing advanced breast and prostate cancers.

Child and Adolescent Psychiatrist and Psychodynamic Psychotherapist with special clinical interest in child and adolescent depression, anxiety, personality disorders, attachment disorders, child trauma and loss, gender identity disorders, psychosomatic/ liaison psychiatry and wellbeing and safeguarding of children and families. Integrative part of my work are specialised individual and systemic therapeutic approaches (Psychodynamic Psychotherapy, Interpersonal Psychotherapy, Group therapy, Mentalisation-Based Treatment, Family Therapy) and use of psychopharmacology in preventing and treating mental health disorders in children and adolescents. I am Clinical Teacher at Leicester University and Clinical and Educational Supervisor for trainee doctors in Psychiatry/ Child Psychiatry Training, CAMHS Lead on the Care Pathways for Depression, Personality Disorders and Attachment Disorders, and CAMHS County Lead for Consultants. I am passionate about clinical training and teaching, prevention and early intervention and safeguarding of children, young people and families, particularly those affected by Parental Mental Illness, which lead me to develop the ‘Think Family - Whole Family Programme: Improving Outcomes for families with parental mental illness. The programme aims of gradually building, both an extensive service-sector skill-set, and an expanding professional awareness. Amongst the key components of the Think Family Programme are the Multiagency (health, education, social care and voluntary services) Training, Early Help Services Training, and Schools Training in Leicester, Leicestershire and Rutland, and Leicestershire Partnership NHS Trust wide 'Think Family-Whole Family Clinical Audit'. The Programme is underpinning significant change in clinical practice, such as routine identification of parents with mental illness and their children, family-focused assessment and practice, and multi-agency collaboration in supporting families. Both, the training programme and the audit have been published in a number of peer reviewed journals. As a Lead for Medical and Clinical Leadership in my Trust, I developed the Medical Leadership Strategy and Implementation Programme. I am experienced and skilled in Management, Organisational Dynamics and Wellbeing of Employees. I have written a range of specialised CAMHS and Safeguarding reviews, protocols and procedures; policy and strategy papers; clinical audits and papers in peer reviewed journals. I have organised, chaired and presented at a number of regional, national and international workshops and conferences.

A man of vision and dynamism with determination to succeed! Dr Sherif Fahmy is a Professor of Pharmacy & Dean for Scientific Affair at University of Nottingham (01/2010 - Present). Dr Fahmy is a Cofounder Business Development at Biocity Limited (03/2009 - Present), which is the largest science incubator in the United Kingdom. Dr Fahmy is also founder & Chief Business Officer at AI Pharma Ltd (10/2020 - Present).Additionally, Dr sherif is a Chief Research & Development Innovation director at Pfizer (02/2013 - Present), which is a leading research-based biopharmaceutical company. A world leader in the field of AI in pharma and healthcare sectors.

Fellow of European Society of Cardiology (ESC) since 1991. National Fellow of the Specialist Certification of Obesity Professionals in TER Europe (EASO). Committee member of Slovak Hypertension Society, long-term committee member, vicepresident and honorary member of Slovak Society of Cardiology, now the chairman of the working group for cardiovascular rehabilitation. 25 years lecturer and cardiologist in Faculty Hospital in Martin, Slovakia, in 1991-1993 vicedean of Jessenius Medical Faculty. Founder and head of Dom srdca in Martin since 1997 (coupling of cardiorestaurant and cardiofitness with dept. of cardiology for out-patients), author of social game for reaching optimal weight CALORIES". Head of consultants for common World Bank and Slovak Ministry of Health Project „Analysis of optional ways of preventative health financing" in 2001. Since 2019 the member of the Slovak Ministry of Health committee for Standard Procedures in Prevention Area. Since 2019 till now the National coordinator for cardiovascular prevention in Slovakia at ESC.

Dr. Shumaila Tunio is the Professor of Microbiology in University of Pikeville, USA. Her main subjects are Medical Immunology, Medical Microbiology, Infectious Diseases, General Microbiology, Biochemistry, Integrated Case Studies, Critical Evaluation of Medical Literatures, Laboratory Research Methods, Techniques in Molecular Biology. MBA in Professional track, Coleman College of Business, University of Pikeville, Pikeville, KY. USA. She completed BSc, Microbiology, Faculty of Science, Kuwait University, Kuwait, MSc, Medical Microbiology, Faculty of Medicine, Kuwait University, Kuwait PhD, Medical Microbiology, Faculty of Medicine, Kuwait University, Kuwait.

Dr. Liselotte Mettler is honorary member of the German Society of Obstetrics and Gynecology, of the German, European and American Society of Gynaecologic Endoscopic Surgery and of the German European and American Society of Reproductive Medicine. At present she is Deputy Director der “Universitären Kinderwunsch Sprechstunde” am Universitätsklinikum Schleswig-Holstein, Kiel and Honorary Patron of the Kiel School of Gynaecological Endoscopy. She is the Executive Director of the International Academy of Human Reproduction (IAHR)and organized the IAHR - World Conference in Venice, Italy, in 2023. In 202O she was awarded with the Honorary membership of the American Society of Gynaecology and Obstetrics and with the Cross of Merit of the Government of the state Schleswig Holstein in Kiel, Germany, where she lives since 1961. In 2022 the “ Deutsche Gesellschaft of Gynaecology and Obstetrics “ honoured her with the “Karl Kaufmann medal in gold”, which is the highest achievement a gynaecologist can receive in Germany In November 2023 she became honorary member of the American Society of Gynaecological Laparoscopy (AAGL) in Nashville, Tennessee. In 2024 she she is all around and served globally in many professional obligations ( AGE, ESGE, ISGE , ESGE, AAGL and ESHRE). Her main fields of activity are Reproductive Medicine, Gynaecological Endoscopy and Gynaecological Endocrinology. Prof. Mettler is actively participating in many societies and organizations. She has written over 1000 publications, 25 books and 9 textbooks, the last one in 2024.

Currently a Consultant Colorectal Surgeon (UAE & UK), the CEO for Healthcare at Ocean 6 (ADGM UAE based Company, UAE), Managing Director & CEO at Global Medical Technology LTD (U.K.). At the helm of GMT Ltd, my strategic vision centers on elevating patient care through innovative programs and global health service restructuring. This leadership role builds on 19+ years as an Executive Board Member, where my expertise in board operations and creativity has significantly contributed to enhancing healthcare productivity and patient safety. The mission driving my tenure at OCEAN 6 and GMT Ltd has been to support health organizations in turnaround programs and help in upscaling healthcare related investments, often in collaboration with entities like the WHO. Our team's dedication to healthcare excellence and management innovation reflects a deep commitment to impacting patient well-being on an international scale. As an international reference and expert in Colorectal Surgery, Intraperitoneal Adhesions and Surgery for Barabash Syndrome patients. I served patients in UAE for the last decade with patients base extends over the UAE & the GCC & MENA region (Consultant Colorectal Surgeon (Abu Dhabi) this was augmented by over 2 decades of experience in UK & the USA (Director of Surgical Services in Ipswich Hospital NHS Trust, Regional lead for Surgical specialities,trainned in UCL (BST), Oxford & Cambridge (HST), Cleveland Clinic Florida (Fellowship) and carried Surgical Science research in Wellcome Foundation UK. In the near past I was Burjeel Holdings Group Medical Director (GMD) & CEO of Burjeel Hospital. Participated in Burjeel Holdings IPO and played a major role in Burjeel Holdings ESG compliant transformation (achieving an AAA rating). Was an elected NHS Governor in UK, .

Taoufik Guizani is a seasoned healthcare leader with over 25 years of experience in nursing and allied health services management across the Middle East and North Africa. He currently serves as the Head of Nursing Services and Allied Health at ApexHealth, where he leads initiatives focused on advancing patient care, optimizing staff development, and improving operational efficiency. Taoufik has held significant leadership roles throughout his career, including Director of Nursing at Burjeel Medical City in Abu Dhabi, UAE, where he played a key role in shaping hospital policies, recruitment strategies, and risk management frameworks. His extensive experience also includes positions at Ain Al Khaleej Hospital, Dr. Abdulrahman Al Mishari Hospital, and Dr. Suleiman Al-Habib Hospital in Saudi Arabia. Taoufik holds a Master of Business Administration from Anglia Ruskin University, UK, and several international certifications in healthcare management. Fluent in Arabic, French, and English, he is committed to advancing nursing and allied health services while driving continuous improvement in patient care.

Prof. Matt Riemann is a multi-award winning speaker and highly sought-after authority in the fields of precision health, future medicine and Ai technology. He has been sought after by the USA, South America, China, European and Australian federal governments, global organizations such as the United Nations, World Economic Forum and World Health Organization, as well as assisting many high profile global thought leaders, leadership councils and medical authorities across the globe.